Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel bio-inspired lipid nanoparticles for improving the anti-tumoral efficacy of fisetin against breast cancer
S. Talaat, Yosra S.R. Elnaggar, Samar O. El-Ganainy, et al.
International Journal of Pharmaceutics (2022) Vol. 628, pp. 122184-122184
Closed Access | Times Cited: 16

Showing 16 citing articles:

Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment
Pablo Graván, Aixa Aguilera-Garrido, Juan Antonio Marchal, et al.
Advances in Colloid and Interface Science (2023) Vol. 314, pp. 102871-102871
Open Access | Times Cited: 56
The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC)
Reyhaneh Farghadani, Rakesh Naidu
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115170-115170
Open Access | Times Cited: 43
Chondroitin/Lactoferrin-dual functionalized pterostilbene-solid lipid nanoparticles as targeted breast cancer therapy
Sara Aly, Amal H. El-Kamel, Eman Sheta, et al.
International Journal of Pharmaceutics (2023) Vol. 642, pp. 123163-123163
Closed Access | Times Cited: 26
The development of nanocarriers for natural products
Liying Huang, Shicui Luo, Sen Tong, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 3
Closed Access | Times Cited: 5
Flavonoids as promising anticancer therapeutics: Contemporary research, nanoantioxidant potential, and future scope
Mukta Gupta, Javed Ahmad, Javed Ahamad, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 5159-5192
Closed Access | Times Cited: 13
Self-assembled fisetin-phospholipid complex: Fisetin-integrated phytosomes for effective delivery to breast cancer
S. Talaat, Yosra S.R. Elnaggar, Samar O. El-Ganainy, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 189, pp. 174-188
Closed Access | Times Cited: 12
Targeted Fisetin-Encapsulated β-Cyclodextrin Nanosponges for Breast Cancer
Alaa R. Aboushanab, Riham M. El‐Moslemany, Amal H. El-Kamel, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1480-1480
Open Access | Times Cited: 10
Codelivery of ivermectin and methyl dihydrojasmonate in nanostructured lipid carrier for synergistic antileukemia therapy
Fatma S. Abou-Elnour, Salma E. El-Habashy, Marwa M. Essawy, et al.
International Journal of Pharmaceutics (2024) Vol. 656, pp. 124086-124086
Closed Access | Times Cited: 3
A drug repurposing approach of Atorvastatin calcium for its antiproliferative activity for effective treatment of breast cancer: In vitro and in vivo assessment
Dina M. Gaber, Sherihan Salaheldin Abdelhamid Ibrahim, Ashraf K. Awaad, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100249-100249
Open Access | Times Cited: 3
Fisetin, a dietary flavonoid, increases the sensitivity of chemoresistant head and neck carcinoma cells to cisplatin possibly through HSP90AA1/IL‐17 pathway
Junjun Ling, Liang Zhang, Yan Wang, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 5, pp. 1997-2011
Closed Access | Times Cited: 9
Role of Fisetin in Selected Malignant Neoplasms in Women
Anna Markowska, Michał Antoszczak, Karol Kacprzak, et al.
Nutrients (2023) Vol. 15, Iss. 21, pp. 4686-4686
Open Access | Times Cited: 8
Novel PEGylated cholephytosomes for targeting fisetin to breast cancer: in vitro appraisal and in vivo antitumoral studies
S. Talaat, Yosra S.R. Elnaggar, Mennatallah A. Gowayed, et al.
Drug Delivery and Translational Research (2023) Vol. 14, Iss. 2, pp. 433-454
Open Access | Times Cited: 6
Plausible role of oral Fisetin-loaded chitosan oligosaccharide nanoparticles in amelioration of benign prostatic hypertrophy: In vitro and in vivo assessments
Randa Hanie Awadeen, Mariza Fouad Boughdady, Randa A. Zaghloul, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105423-105423
Closed Access | Times Cited: 1
Newly synthesized chitosan nanoparticles loaded with caffeine/moringa leaf extracts Halt Her2, BRCA1, and BRCA2 expressions
Hanaa Mohammed, Mustafa M. Karhib, Karrar Sabah Jaafar Al-Fahad, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Microneedles integrated with atorvastatin-loaded pumpkisomes for breast cancer therapy: A localized delivery approach
Lamia Heikal, Asmaa A. Ashour, Alaa R. Aboushanab, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 354-368
Closed Access | Times Cited: 1
An Insight into Fisetin, The Miraculous Multifaceted Flavonol: Paving the Road for Enhanced Delivery Through Promising Pharmaceutical Nano-Formulations.
Asmaa H. Elwan, Soha M. El-Masry, Doaa A. Habib, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106292-106292
Closed Access
Page 1

Scroll to top